Syndrome of mild cognitive impairment

Cover Page

Cite item

Full Text

Abstract

Mild cognitive impairment (MCI) is commonly known by an impaired memory and other higher brain functions, as a rule, demonstrated in elderly persons who are outside the age-related standard range, but do not lead to social exclusion, by not causing dementia. MCI are a polyetiologic syndrome that may develop within a wide range of neurological diseases. Most often a clinical MCI diagnosis of the syndrome matches the pathological markers of neurodegeneration and cerebral vascular insufficiency. It has been shown that clinical and subclinical orthostatic hypotension are associated with impaired cognitive function, decreased activity, motivation and an increased risk of dementia, diabetes and Parkinson's disease. Pronoran (piribedil) combines the dopaminergic and noradrenergic properties; its effectiveness has been studied and has been proven in more than 15 clinical studies, which were attended by a total of more than 7 thousand patients from around the world.

About the authors

O. V Kotova

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Email: ol_kotova@mail.ru
канд. мед. наук, ст. науч. сотр., врач-невролог НИО неврологии НИЦ ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

References

  1. Яхно Н.Н., Захаров В.В. Легкие когнитивные расстройства в пожилом возрасте. Неврол. журн. 2004; 9 (1): 4-8.
  2. Международная статистическая классификация болезней и проблем, связанных со здоровьем. Десятый пересмотр (МКБ-10). Женева, ВОЗ, 1995: 317.
  3. Яхно Н.Н., Преображенская И.С. Деменция с тельцами Леви. Неврол. журн. 2003; 8 (6): 4-11.
  4. ахаров В.В., Яхно Н.Н. Нарушения памяти. М.: ГЭОТАР-Мед, 2003; с. 150.
  5. Petersen R.C, Stevens J.C, Ganguli M et al Practice parameter. Early detection of dementia: mild cognitive impairment (an evidencebased review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1133-42.
  6. Petersen R, Touchon J. Consensus on mild cognitive impairment. Research and practice in Alzheimer’s disease. EADS-ADCS joint meeting 2005; 10: 24-32.
  7. Дамулин И.В. Болезнь Альцгеймера и сосудистая деменция. Под ред. Н.Н.Яхно. М., 2002; с. 85.
  8. Mathias C.J. Orthostatic hypotension: causes, mechanisms, and influencing factors. Neurology 1995; 45: S6-S11.
  9. Fan X.H, Wang Y, Sun K et al. Disorders of orthostatic blood pressure response are associated with cardiovascular disease and target organ damage in hypertensive patients. Am J Hypertens 2010; 23: 829-37.
  10. Rose K.M, Couper D, Eigenbrodt M.L et al. Orthostatic hypotension and cognitive function: the Atherosclerosis Risk in Communities Study. Neuroepidemiology 2010; 34 (1): 1-7.
  11. Schoon Y, Lagro J, Verhoeven Y et al. Hypotensive syndromes are not associated with cognitive impairment in geriatric patients. Am J Alzheimers Dis Other Demen 2013; 28 (1): 47-53.
  12. Allan L.M, Ballard C.G, Allen J et al. Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry 2007; 78 (7): 671-7.
  13. Mehrabian S, Duron E, Labouree F et al. Relationship between orthostatic hypotension and cognitive impairment in the elderly. J Neurol Sci 2010; 299 (1-2): 45-8.
  14. Elmstáhl S, Rosén I. Postural hypotension and EEG variables predict cognitive decline: results from a 5-year follow - up of healthy elderly women. Dement Geriatr Cogn Disord 1997; 8 (3): 180-7.
  15. Perlmuter L.C, Sarda G, Casavant V et al. A review of orthostatic blood pressure regulation and its association with mood and cognition. Clin Auton Res 2012; 22 (2): 99-107.
  16. Rutan G.H, Hermanson B, Bild D.E et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension 1992; 19: 508-19.
  17. Cooper C, Sommerlad A, Lyketsos C.G, Livingston G. Modifiable Predictors of Dementia in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. Am J Psychiatry 2015: appiajp 201414070878.
  18. Левин О.С. Современные подходы к диагностике и лечению деменции. Справ. поликлин. врача. 2007; 1 (5): 4-12.
  19. Яхно Н.Н., Лавров А.Ю. Изменения центральной нервной системы при старении. Нейродегенеративные болезни и старение (руководство для врачей). Под ред. И.А.Завалишина, Н.Н.Яхно, С.И.Гавриловой. М., 2001; с. 242-61.
  20. Яхно Н.Н., Преображенская И.С. Проноран в лечении больных с ранними стадиями болезни Паркинсона. Неврол. журн. 2004; 9 (6): 34-8.
  21. Захаров В.В., Локшина А.Б. Применение препарата Проноран (пирибедил) при легких когнитивных расстройствах у пожилых больных с дисциркуляторной энцефалопатией. Неврол. журн. 2004; 2: 30-5.
  22. Nagaraia D, Jayashree S. Randomised study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment. Am J Psychiat 2001; 158 (9): 1517-9.
  23. Захаров В.В. Распространенность и лечение когнитивных нарушений в неврологической клинике (Результаты Всероссийского исследования «ПРОМЕТЕЙ»). Consilium Medicum. 2008; 2: 114-8.
  24. Кадыков А.С., Черникова Л.А., Шахпаронова Н.В. Реабилитация больных с нарушениями мозгового кровообращения при артериальной гипертонии. Пособие для врачей. М., 2003.
  25. Котова О.В., Акарачкова Е.С. Хроническая ишемия головного мозга: патогенетические механизмы и принципы лечения. Фарматека. 2010; 8: 57-61.

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies